Literature DB >> 30794477

Strategies for Evaluation of Novel Imaging in Prostate Cancer: Putting the Horse Back Before the Cart.

Neha Vapiwala1, Michael S Hofman2,3, Declan G Murphy2,3, Scott Williams2,3, Christopher Sweeney4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30794477     DOI： 10.1200/JCO.18.01927

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer.

Authors:  Ali H D Alshehri; Sarah O S Osman; Kevin M Prise; Caoimhghin Campfield; P G Turner; Suneil Frcr PhD Jain; Joe M O'Sullivan; Aidan J Cole
Journal:  Br J Radiol       Date:  2020-09-03       Impact factor: 3.039

Review 2.  Navigating systemic therapy for metastatic castration-naïve prostate cancer.

Authors:  E M Kwan; I A Thangasamy; J Teh; O Alghazo; N J Sathianathen; N Lawrentschuk; A A Azad
Journal:  World J Urol       Date:  2020-01-02       Impact factor: 4.226

3.  Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer.

Authors:  Bobby Shaygan; Katherine Zukotynski; François Bénard; Cynthia Ménard; Joda Kuk; Golmehr Sistani; Glenn Bauman; Patrick Veit-Haibach; Ur Metser
Journal:  Can Urol Assoc J       Date:  2021-06       Impact factor: 1.862

4.  Prostate-specific membrane antigen (PSMA) imaging: the past is prologue and the future is scintillating.

Authors:  Steven P Rowe; Michael A Gorin; Martin G Pomper
Journal:  Transl Androl Urol       Date:  2020-04

Review 5.  Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?

Authors:  Ramin Alipour; Arun Azad; Michael S Hofman
Journal:  Ther Adv Med Oncol       Date:  2019-09-20       Impact factor: 8.168

6.  PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.

Authors:  Julia Murray; Clare Cruickshank; Thomas Bird; Philip Bell; John Braun; Dave Chuter; Miguel Reis Ferreira; Clare Griffin; Shama Hassan; Nabil Hujairi; Alan Melcher; Elizabeth Miles; Olivia Naismith; Miguel Panades; Lara Philipps; Alison Reid; Jan Rekowski; Pete Sankey; John Staffurth; Isabel Syndikus; Alison Tree; Anna Wilkins; Emma Hall
Journal:  Clin Transl Radiat Oncol       Date:  2022-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.